Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 46 results.
User Information
Export Records
  1. 1.   The Metabolic Basis of Kidney Cancer
  2. Linehan, W. Marston; Schmidt,Laura; Crooks, Daniel R.; Wei, Darmood; Srinivasan, Ramaprasad; Lang, Martin; Ricketts, Christopher J.
  3. Cancer discovery. 2019, AUG; 9(8): 1006-1021.
  1. 2.   Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer
  2. Cherkasova, E.; Malinzak, E.; Rao, S.; Takahashi, Y.; Senchenko, V. N.; Kudryavtseva, A. V.; Nickerson, M. L.; Merino, M.; Hong, J. A.; Schrump, D. S.; Srinivasan, R.; Linehan, W. M.; Tian, X.; Lerman, M. I.; Childs, R. W.
  3. Oncogene. 2011, Nov; 30(47): 4697-4706.
  1. 3.   RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis
  2. Lipkowitz, S.; Weissman, A. M.
  3. Nature Reviews Cancer. 2011, Sep; 11(9): 629-643.
  1. 4.   mTOR Kinase Inhibitor AZD8055 Enhances the Immunotherapeutic Activity of an Agonist CD40 Antibody in Cancer Treatment
  2. Jiang, Q.; Weiss, J. M.; Back, T.; Chan, T.; Ortaldo, J. R.; Guichard, S.; Wiltrout, R. H.
  3. Cancer Research. 2011, Jun; 71(12): 4074-4084.
  1. 5.   Proteomic biomarker discovery: It's more than just mass spectrometry
  2. Blonder, J.; Issaq, H. J.; Veenstra, T. D.
  3. Electrophoresis. 2011, Jun; 32(13): 1541-1548.
  1. 6.   Inactivation of the FLCN Tumor Suppressor Gene Induces TFE3 Transcriptional Activity by Increasing Its Nuclear Localization
  2. Hong, S. B.; Oh, H.; Valera, V. A.; Baba, M.; Schmidt, L. S.; Linehan, W. M.
  3. Plos One. 2010, Dec; 5(12): 12.
  1. 7.   Molecular Diagnosis and Therapy of Kidney Cancer
  2. Linehan, W. M.; Bratslavsky, G.; Pinto, P. A.; Schmidt, L. S.; Neckers, L.; Bottaro, D. P.; Srinivasan, R.
  3. Annual Review of Medicine. 2010, Feb; 61: 329-343.
  1. 8.   Lack of Association Between Excretion of Sorafenib in Sweat and Hand-Foot Skin Reaction
  2. Jain, L.; Gardner, E. R.; Figg, W. D.; Chernick, M. S.; Kong, H. H.
  3. Pharmacotherapy. 2010, Jan; 30(1): 52-56.
  1. 9.   Recent Development of Cyclic Amide (Pyridone/Lactam) Moiety Containing Heterocycles as Protein Kinase Inhibitors
  2. Wei, L. Y.; Malhotra, S. V.
  3. Current Medicinal Chemistry. 2010, Jan; 17(3): 234-253.
  1. 10.   Truncation of Histone H2A's C-terminal Tail, as Is Typical for Ni(II)-Assisted Specific Peptide Bond Hydrolysis, Has Gene Expression Altering Effects
  2. Karaczyn, A. A.; Cheng, R.; Buzard, G. S.; Hartley, J.; Esposito, D.; Kasprzak, K. S.
  3. Annals of Clinical and Laboratory Science. 2009 39(3): 251-262.
  1. 11.   Gene expression profiling of alveolar soft-part sarcoma (ASPS)
  2. Stockwin, L. H.; Vistica, D. T.; Kenney, S.; Schrump, D. S.; Butcher, D. O.; Raffeld, M.; Shoemaker, R. H.
  3. Bmc Cancer. 2009 9(22): 1-11.
  1. 12.   Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment
  2. Weiss, J. M.; Back, T. C.; Scarzello, A. J.; Subleski, J. J.; Hall, V. L.; Stauffer, J. K.; Chen, X.; Micic, D.; Alderson, K.; Murphy, W. J.; Wiltrout, R. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(46): 19455-19460.
  1. 13.   Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition
  2. Dang, D. T.; Chun, S. Y.; Burkitt, K.; Abe, M.; Chen, S.; Havre, P.; Mabjeesh, N. J.; Heath, E. I.; Vogelzang, N. J.; Cruz-Correa, M.; Blayney, D. W.; Ensminger, W. D.; Croix, B. S.; Dang, N. H.; Dang, L. H.
  3. Cancer Research. 2008 68(6): 1872-1880.
  1. 14.   Regulation of hypoxia-inducible genes by ETS1 transcription factor
  2. Salnikow, K.; Aprelikova, O.; Ivanov, S.; Tackett, S.; Kaczmarek, M.; Karaczyn, A.; Yee, H.; Kasprzak, K. S.; Niederhuber, J.
  3. Carcinogenesis. 2008 29(8): 1493-1499.
  1. 15.   Tissue-based research in kidney cancer: Current challenges and future directions
  2. Signoretti, S.; Bratslavsky, G.; Waldman, F. M.; Reuter, V. E.; Haaga, J.; Merino, M.; Thomas, G. V.; Pins, M. R.; Libermann, T.; Gillespie, J.; Tomaszewski, J. E.; Compton, C. C.; Hruszkewycz, A.; Linehan, W. M.; Atkins, M. B.
  3. Clinical Cancer Research. 2008 14(12): 3699-3705.
  1. 16.   BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports
  2. Toro, J. R.; Wei, M. H.; Glenn, G. M.; Weinreich, M.; Toure, O.; Vocke, C.; Turner, M.; Choyke, P.; Merino, M. J.; Pinto, P. A.; Steinberg, S. M.; Schmidt, L. S.; Linehan, W. M.
  3. Journal of Medical Genetics. 2008 45(6): 321-331.
  1. 17.   Immunohistochemical discrimination between the ASPL-TFE3 fusion proteins of alveolar soft part sarcoma
  2. Vistica, D. T.; Krosky, P. M.; Kenney, S.; Raffeld, M.; Shoemaker, R. H.
  3. Journal of Pediatric Hematology Oncology. 2008 30(1): 46-52.
  1. 18.   Immunotherapy of cancer by IL-12-based cytokine combinations
  2. Weiss, J. M.; Subleski, J. J.; Wigginton, J. M.; Wiltrout, R. H.
  3. Expert Opinion on Biological Therapy. 2007, Nov; 7(11): 1705-1721.
  1. 19.   RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer gene
  2. Brauweiler, A.; Lorick, K. L.; Lee, J. P.; Tsai, Y. C.; Chan, D.; Weissman, A. M.; Drabkin, H. A.; Gemmill, R. M.
  3. Oncogene. 2007, Apr; 26(16): 2263-2271.
  1. 20.   Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13
  2. Ivanov, S. V.; Salnikow, K.; Ivanova, A. V.; Bai, L.; Lerman, M. I.
  3. Oncogene. 2007, Feb; 26(6): 802-812.
  1. 21.   Meeting report: Exploiting the Tumor Microenvironment for Therapeutics
  2. Melillo, G.; Semenza, G. L.
  3. Cancer Research. 2006, MAY 1; 66(9): 4558-4560.
  1. 22.   Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer
  2. Wei, M. H.; Toure, O.; Glenn, G. M.; Pithukpakorn, M.; Neckers, L.; Stolle, C.; Choyke, P.; Grubb, R.; Middelton, L.; Turner, M. L.; Walther, M. M.; Merino, M. J.; Zbar, B.; Linehan, W. M.; Toro, J. R.
  3. Journal of Medical Genetics. 2006, JAN; 43(1): 18-27.
  1. 23.   In vivo hydrodynamic delivery of cDNA encoding IL-2: Rapid, sustained redistribution, activation of mouse NK cells, and therapeutic potential in the absence of NKT cells
  2. Ortaldo, J. R.; Winkler-Pickett, R. T.; Bere, E. W.; Watanabe, M.; Murphy, W. J.; Wiltrout, R. H.
  3. Journal of Immunology. 2005, JUL 15; 175(2): 693-699.
  1. 24.   Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome
  2. Schmidt, L. S.; Nickerson, M. L.; Warren, M. B.; Glenn, G. M.; Toro, J. R.; Merino, M. J.; Turner, M. L.; Choyke, P. L.; Sharma, N.; Peterson, J.; Morrison, P.; Maher, E. R.; Walther, M. M.; Zbar, B.; Linehan, W. M.
  3. American Journal of Human Genetics. 2005, JUN; 76(6): 1023-1033.
  1. 25.   Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: A clinical and molecular genetic investigation
  2. Matyakhina, L.; Freedman, R. J.; Bourdeau, I.; Wei, M. H.; Stergiopoulos, S. G.; Chidakel, A.; Walther, M.; bu-Asab, M.; Tsokos, M.; Keil, M.; Toro, J.; Linehan, W. M.; Stratakis, C. A.
  3. Journal of Clinical Endocrinology & Metabolism. 2005, JUN; 90(6): 3773-3779.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel